ArticleMolecular therapy oncolytics2020

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma.

Aniello Federico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.